GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Inventory Turnover

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Inventory Turnover : 0.82 (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. GlaxoSmithKline Consumer Nigeria's Cost of Goods Sold for the three months ended in Jun. 2023 was ₦2,418 Mil. GlaxoSmithKline Consumer Nigeria's Average Total Inventories for the quarter that ended in Jun. 2023 was ₦2,961 Mil. GlaxoSmithKline Consumer Nigeria's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.82.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. GlaxoSmithKline Consumer Nigeria's Days Inventory for the three months ended in Jun. 2023 was 111.76.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. GlaxoSmithKline Consumer Nigeria's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.79.


GlaxoSmithKline Consumer Nigeria Inventory Turnover Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Inventory Turnover Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.42 3.11 3.49 3.49 3.77

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.91 0.92 0.84 0.82

GlaxoSmithKline Consumer Nigeria Inventory Turnover Calculation

GlaxoSmithKline Consumer Nigeria's Inventory Turnover for the fiscal year that ended in Dec. 2022 is calculated as

Inventory Turnover (A: Dec. 2022 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2022 ) / ((Total Inventories (A: Dec. 2021 ) + Total Inventories (A: Dec. 2022 )) / count )
=18452.24 / ((6045.4 + 3739.54) / 2 )
=18452.24 / 4892.47
=3.77

GlaxoSmithKline Consumer Nigeria's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover (Q: Jun. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Jun. 2023 ) / ((Total Inventories (Q: Dec. 2022 ) + Total Inventories (Q: Jun. 2023 )) / count )
=2417.612 / ((3739.54 + 2182.243) / 2 )
=2417.612 / 2960.8915
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

GlaxoSmithKline Consumer Nigeria's Days Inventory for the three months ended in Jun. 2023 is calculated as:

Days Inventory =Average Total Inventories (Q: Jun. 2023 )/Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=2960.8915/2417.612*365 / 4
=111.76

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

GlaxoSmithKline Consumer Nigeria's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=2960.8915 / 3731.801
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


GlaxoSmithKline Consumer Nigeria Inventory Turnover Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines